Charles River Laboratories International Inc. is a leading global provider of laboratory services and products that support the pharmaceutical, biotechnology, and medical device industries. The company's mission is to accelerate drug development and improve patient outcomes through innovative research solutions. Charles River Laboratories employs a comprehensive strategy that includes offering a wide range of preclinical and clinical services, as well as advanced technologies and products. Their operations encompass everything from early-stage drug discovery to regulatory compliance, ensuring that clients can navigate the complexities of bringing new therapies to market efficiently and effectively.

CHARLES RIVER LABORATORIES INTERNATIONAL INC

Charles River Laboratories International (CRL) remains a prominent player in the pharmaceutical Contract Research Organization (CRO) market, which is poised for substantial growth, expected to rise from USD 40 billion in 2023 to USD 75.7 billion by 2032, at a compound annual growth rate (CAGR) of 7.36%. This growth presents...

Charles River Laboratories Strives for Growth Amid Challenges, Enhances Capabilities in Drug Discovery and Safety Testing Through Strategic Acquisitions and Partnerships

Charles River Laboratories Strives for Growth Amid Challenges, Enhances Capabilities in Drug Discovery and Safety Testing Through Strategic Acquisitions and Partnerships

Charles River Laboratories is navigating a challenging landscape while strategically enhancing its capabilities in drug discovery and safety testing. With the CRO market poised for significant growth, can CRL turn its recent setbacks into a springboard for future success?